Login / Signup

Feasibility of marker-less stereotactic body radiotherapy for hepatocellular carcinoma.

Yuichi KibeAtsuya TakedaYuichirou TsurugaiTakahisa EriguchiYohei OkuYuto KimuraNaoki Nakamura
Published in: Acta oncologica (Stockholm, Sweden) (2021)
Marker-less SBRT for HCC achieved favorable local control that fulfilled the threshold. This result suggests that marker-less SBRT with appropriate settings is a feasible treatment strategy.
Keyphrases
  • radiation therapy
  • early stage
  • squamous cell carcinoma
  • replacement therapy